If you are not happy with the results below please do another search
Berlin-based ProBioGen AG has signed a commercial multi-product license agreement with Sanofi. Under the agreement, Sanofi will integrate ProBioGen’s proprietary GlymaxX technology into their product development strategy for an undisclosed number of antibody candidates across several business units. GlymaxX enables a boost of antibody-dependent cell-mediated cytotoxicity (ADCC), consequently leading to an elevated NK cell mediated […]
Researchers from Chalmers University of Technology, Sweden have developed Artificial Intelligence that is capable of generating novel, functionally active proteins. The research represents a significant breakthrough in the field of synthetic protein development. “What we are now able to demonstrate offers fantastic potential for a number of future applications, such as faster and more cost-efficient development […]
Axol Bioscience, an established provider of iPSC-derived cells, media, and characterization services, has merged with CENSO Biotechnologies, a cell biology CRO with focused expertise in iPSC-related technologies. The new entity will become a leading provider of product and service solutions in the iPSC-based neuroscience, immune cell, and cardiac modeling for drug discovery and screening markets. […]
Despite significant progress in its prevention and treatment, human immunodeficiency virus (HIV) remains a serious public health threat across the globe. The United Nations programme UNAIDS has led the global effort to address the HIV/ AIDS crisis and has set out its 90-90-90 target: 90 percent of all people living with HIV (PLHIV) will know […]
Siemens Healthineers and Sysmex Corporation have renewed their long-standing global supply, distributorship, sales and service agreement for a broad portfolio of haemostasis products including a multi-year extension. Additionally, the companies’ agreement includes the future distribution of Sysmex’s CN-Series automated blood coagulation analysers, the CN-3000 and CN-6000, by Siemens Healthineers bringing the next generation of fully-automated […]
Albumedix, a Nottingham, UK-based biotech company and world leader in recombinant human albumin (rAlb), will collaborate with the Cell and Gene Therapy Catapult (CGT Catapult) to investigate the use of Albumedix’s proprietary albumin-based solutions for advanced therapy applications, including viral vectors manufacturing.
SPT Labtech, a global leader in the design and development of automated instrumentation and consumables for life science applications, has acquired BioMicroLab, a robotics automation provider for life science laboratories.
NovalGen, a biopharmaceutical company developing breakthrough cancer therapies and HALIX B.V., a contract development and manufacturing organisation, have agreed a strategic partnership wherein HALIX will manufacture clinical supplies for NovalGen’s therapies.
WuXi AppTec, a Shanghai, China-headquartered global provider of R&D- and manufacturingenabling services in the pharmaceutical, biotechnology and medical device industries, has acquired OXGENE, a pioneering United Kingdom-based contract research and development organization that designs and develops scalable gene therapy technologies. This acquisition enables WuXi AppTec to offer its customers end-to-end support in the creation and […]
La Jolla Institute for Immunology (LJI), a leading research organization focussed on studying the immune system has signed a licensing agreement with Leinco Technologies, a premier developer and manufacturer of leading-edge recombinant proteins, antibodies, and conjugates. Leinco also provides custom manufacturing services to the diagnostic and biopharmaceutical industries to leverage proprietary COVID-19 antibodies developed at […]
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
